|
Sep 28
|
Amgen initiated with an Overweight at Cantor Fitzgerald
|
|
Sep 27
|
Regeneron Shares Head for Worst Month Since 2019 on Legal Ruling
|
|
Sep 27
|
Amgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts
|
|
Sep 26
|
AMGN Stock Falls Despite Upbeat Data on Immunology Drugs: Here's Why
|
|
Sep 25
|
Amgen stock falls on lackluster drug data
|
|
Sep 25
|
Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
|
|
Sep 25
|
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
|
|
Sep 25
|
Amgen Stock Falls on Disappointing Drug Data
|
|
Sep 25
|
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
|
|
Sep 25
|
Amgen claims success for two immune drugs, but results underwhelm Wall Street
|
|
Sep 24
|
TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE
|
|
Sep 3
|
Amgen Insiders Sell US$4.0m Of Stock, Possibly Signalling Caution
|
|
Sep 3
|
Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring
|
|
Aug 30
|
AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
|
|
Aug 30
|
The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
|
|
Aug 29
|
AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
|
|
Aug 28
|
Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound
|
|
Aug 27
|
With 79% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns
|
|
Aug 25
|
3 Unstoppable Dividend Stocks to Buy Right Now
|
|
Jul 30
|
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
|